Meningococcal (Men B)

Meningococcal Serogroup B  (aka Trumenba or Bexsero)

Recommended between 16 to 18 years of age. 

(if local outbreak; absent or damaged spleen; complement deficiency)

16-18 years  Two doses at least six months apart